Literature DB >> 28071824

Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease.

Naomi P Visanji1, Grace S Bhudhikanok2, Tiago A Mestre1, Taneera Ghate1, Kaviraj Udupa3, Amaal AlDakheel1, Barbara S Connolly1, Carmen Gasca-Salas1, Drew S Kern1, Jennifer Jain1, Elizabeth J Slow1, Achinoam Faust-Socher1, Sam Kim2, Ruksana Azhu Valappil2, Farah Kausar2, Ekaterina Rogaeva4, J William Langston2, Caroline M Tanner5,6, Birgitt Schüle2, Anthony E Lang1, Samuel M Goldman5,6, Connie Marras1.   

Abstract

BACKGROUND: Heart rate variability is reduced in idiopathic PD, indicating cardiac autonomic dysfunction likely resulting from peripheral autonomic synucleinopathy. Little is known about heart rate variability in leucine-rich repeat kinase 2-associated PD.
OBJECTIVES: This study investigated heart rate variability in LRRK2-associated PD.
METHODS: Resting electrocardiograms were obtained from 20 individuals with LRRK2-associated PD, 37 nonmanifesting carriers, 48 related noncarriers, 26 idiopathic PD patients, and 32 controls. Linear regression modelling compared time and frequency domain values, adjusting for age, sex, heart rate, and disease duration.
RESULTS: Low-frequency power and the ratio of low-high frequency power were reduced in idiopathic PD versus controls (P < .008, P < .029 respectively). In contrast, individuals with LRRK2-associated PD were not statistically different from controls in any parameter measured. Furthermore, all parameters trended toward being higher in LRRK2-associated PD when compared with idiopathic PD.
CONCLUSIONS: Heart rate variability may remain intact in LRRK2-associated PD, adding to a growing literature supporting clinical-pathologic differences between LRRK2-associated and idiopathic PD.
© 2017 International Parkinson and Movement Disorder Society. © 2017 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  LRRK2; Parkinson's disease; autonomic dysfunction; heart rate variability

Mesh:

Substances:

Year:  2017        PMID: 28071824     DOI: 10.1002/mds.26896

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  5 in total

1.  Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease.

Authors:  Claudia Carricarte Naranjo; Connie Marras; Naomi P Visanji; David J Cornforth; Lazaro Sanchez-Rodriguez; Birgitt Schüle; Samuel M Goldman; Mario Estévez; Phyllis K Stein; Anthony E Lang; Herbert F Jelinek; Andrés Machado
Journal:  Clin Auton Res       Date:  2019-08-23       Impact factor: 4.435

2.  Bioinformatic gene analysis for potential biomarkers and therapeutic targets of atrial fibrillation-related stroke.

Authors:  Rongjun Zou; Dingwen Zhang; Lei Lv; Wanting Shi; Zijiao Song; Bin Yi; Bingjia Lai; Qian Chen; Songran Yang; Ping Hua
Journal:  J Transl Med       Date:  2019-02-13       Impact factor: 5.531

3.  Dysautonomia in Parkinson's Disease: Impact of Glucocerebrosidase Gene Mutations on Cardiovascular Autonomic Control.

Authors:  Angelica Carandina; Giulia Lazzeri; Gabriel Dias Rodrigues; Giulia Franco; Edoardo Monfrini; Federica Arienti; Emanuele Frattini; Ilaria Trezzi; Pedro Paulo da Silva Soares; Chiara Bellocchi; Ludovico Furlan; Nicola Montano; Alessio Di Fonzo; Eleonora Tobaldini
Journal:  Front Neurosci       Date:  2022-03-15       Impact factor: 4.677

4.  Short-term deceleration capacity of heart rate: a sensitive marker of cardiac autonomic dysfunction in idiopathic Parkinson's disease.

Authors:  Claudia Carricarte Naranjo; Connie Marras; Naomi P Visanji; David J Cornforth; Lazaro Sanchez-Rodriguez; Birgitt Schüle; Samuel M Goldman; Mario Estévez; Phyllis K Stein; Anthony E Lang; Herbert F Jelinek; Andrés Machado
Journal:  Clin Auton Res       Date:  2021-07-12       Impact factor: 4.435

Review 5.  Mural Cells: Potential Therapeutic Targets to Bridge Cardiovascular Disease and Neurodegeneration.

Authors:  Alexander Lin; Niridu Jude Peiris; Harkirat Dhaliwal; Maria Hakim; Weizhen Li; Subramaniam Ganesh; Yogambha Ramaswamy; Sanjay Patel; Ashish Misra
Journal:  Cells       Date:  2021-03-08       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.